A New York City-based Memorial Sloan Kettering Cancer Center found only 35 percent of Americans cited being "likely" to enroll in a clinical trail, according to Science Daily.
Researchers surveyed more than 1,500 consumers and almost 600 physicians.
Here are five notes:
1. Other studies have found only 4 percent of cancer patients enroll in clinical trials annually.
2. Forty percent of respondents reported having a positive overall impression of clinical trials.
3. After receiving education about clinical trials, 40 percent to 60 percent of respondents reported viewing clinical trials positively, overall.
4. Consumer barriers to clinical trial enrollment include worry over its side effects (55 percent); uncertainty about insurance and out-of-pocket costs (50 percent); inconvenient trial location (48 percent); concern about getting a placebo (46 percent); skepticism of a treatment that is not yet proven to work (35 percent); and concern over feeling like "guinea pigs" (34 percent).
5. Physicians cited barriers such as getting a placebo (63 percent), safety (63 percent) feeling like "guinea pgs" (53 percent).
More articles on quality & infection control:
Black Book Research places Modernizing Medicine at #1 — 4 highlights
Tension builds as legislators debate Zika funding: 3 notes
Understanding human flaws could cause less medical errors — 3 points
